 | • レポートコード：D0804-00629 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アンチエイジング薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。アンチエイジング薬の種類別市場規模（ホルモン療法、抗酸化剤、酵素、幹細胞、その他）、用途別市場規模（肌、髪、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Nu Skin、La Roche-Posay、BIOTIME、Elysium Health、DermaFix ・地域別グローバル市場分析 2015年-2020年 ・アンチエイジング薬の北米市場（アメリカ、カナダ、メキシコ） ・アンチエイジング薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アンチエイジング薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アンチエイジング薬の南米市場（ブラジル、アルゼンチン） ・アンチエイジング薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ホルモン療法、抗酸化剤、酵素、幹細胞、その他 ・用途別分析：肌、髪、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anti-Ageing Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.2% in the forecast period of 2020 to 2025 and will expected to reach USD 106360 million by 2025, from USD 80490 million in 2019.
The Anti-Ageing Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-Ageing Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-Ageing Drugs market has been segmented into
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
By Application, Anti-Ageing Drugs has been segmented into:
Skin
Hair
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-Ageing Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-Ageing Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-Ageing Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anti-Ageing Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-Ageing Drugs Market Share Analysis
Anti-Ageing Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-Ageing Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-Ageing Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anti-Ageing Drugs are:
Nu Skin
La Roche-Posay
BIOTIME
Elysium Health
DermaFix
Among other players domestic and global, Anti-Ageing Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Ageing Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Ageing Drugs, with price, sales, revenue and global market share of Anti-Ageing Drugs in 2018 and 2019.
Chapter 3, the Anti-Ageing Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Ageing Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-Ageing Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-Ageing Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti-Ageing Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Ageing Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hormonal Therapy
1.2.3 Antioxidants
1.2.4 Enzymes
1.2.5 Stem Cells
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Ageing Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Skin
1.3.3 Hair
1.3.4 Others
1.4 Overview of Global Anti-Ageing Drugs Market
1.4.1 Global Anti-Ageing Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Nu Skin
2.1.1 Nu Skin Details
2.1.2 Nu Skin Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Nu Skin SWOT Analysis
2.1.4 Nu Skin Product and Services
2.1.5 Nu Skin Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 La Roche-Posay
2.2.1 La Roche-Posay Details
2.2.2 La Roche-Posay Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 La Roche-Posay SWOT Analysis
2.2.4 La Roche-Posay Product and Services
2.2.5 La Roche-Posay Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BIOTIME
2.3.1 BIOTIME Details
2.3.2 BIOTIME Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BIOTIME SWOT Analysis
2.3.4 BIOTIME Product and Services
2.3.5 BIOTIME Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Elysium Health
2.4.1 Elysium Health Details
2.4.2 Elysium Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Elysium Health SWOT Analysis
2.4.4 Elysium Health Product and Services
2.4.5 Elysium Health Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 DermaFix
2.5.1 DermaFix Details
2.5.2 DermaFix Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DermaFix SWOT Analysis
2.5.4 DermaFix Product and Services
2.5.5 DermaFix Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-Ageing Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-Ageing Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Ageing Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-Ageing Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-Ageing Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Ageing Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-Ageing Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-Ageing Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-Ageing Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-Ageing Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-Ageing Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-Ageing Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-Ageing Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
6.4 France Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-Ageing Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-Ageing Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-Ageing Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
7.5 India Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-Ageing Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-Ageing Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-Ageing Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-Ageing Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-Ageing Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-Ageing Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-Ageing Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anti-Ageing Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-Ageing Drugs Price by Type (2015-2020)
11 Global Anti-Ageing Drugs Market Segment by Application
11.1 Global Anti-Ageing Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anti-Ageing Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anti-Ageing Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-Ageing Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-Ageing Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-Ageing Drugs Market Forecast (2021-2025)
12.2.2 Europe Anti-Ageing Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-Ageing Drugs Market Forecast (2021-2025)
12.2.4 South America Anti-Ageing Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-Ageing Drugs Market Forecast (2021-2025)
12.3 Anti-Ageing Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anti-Ageing Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-Ageing Drugs Market Share Forecast by Type (2021-2025)
12.4 Anti-Ageing Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anti-Ageing Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-Ageing Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti-Ageing Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Ageing Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Ageing Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Nu Skin Basic Information, Manufacturing Base and Competitors
Table 8. Nu Skin Anti-Ageing Drugs Major Business
Table 9. Nu Skin Anti-Ageing Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Nu Skin SWOT Analysis
Table 11. Nu Skin Anti-Ageing Drugs Product and Services
Table 12. Nu Skin Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. La Roche-Posay Basic Information, Manufacturing Base and Competitors
Table 14. La Roche-Posay Anti-Ageing Drugs Major Business
Table 15. La Roche-Posay Anti-Ageing Drugs Total Revenue (USD Million) (2017-2018)
Table 16. La Roche-Posay SWOT Analysis
Table 17. La Roche-Posay Anti-Ageing Drugs Product and Services
Table 18. La Roche-Posay Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. BIOTIME Basic Information, Manufacturing Base and Competitors
Table 20. BIOTIME Anti-Ageing Drugs Major Business
Table 21. BIOTIME Anti-Ageing Drugs Total Revenue (USD Million) (2017-2018)
Table 22. BIOTIME SWOT Analysis
Table 23. BIOTIME Anti-Ageing Drugs Product and Services
Table 24. BIOTIME Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Elysium Health Basic Information, Manufacturing Base and Competitors
Table 26. Elysium Health Anti-Ageing Drugs Major Business
Table 27. Elysium Health Anti-Ageing Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Elysium Health SWOT Analysis
Table 29. Elysium Health Anti-Ageing Drugs Product and Services
Table 30. Elysium Health Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. DermaFix Basic Information, Manufacturing Base and Competitors
Table 32. DermaFix Anti-Ageing Drugs Major Business
Table 33. DermaFix Anti-Ageing Drugs Total Revenue (USD Million) (2017-2018)
Table 34. DermaFix SWOT Analysis
Table 35. DermaFix Anti-Ageing Drugs Product and Services
Table 36. DermaFix Anti-Ageing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Anti-Ageing Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Anti-Ageing Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Anti-Ageing Drugs Sales by Regions (2015-2020) (K Units)
Table 40. Global Anti-Ageing Drugs Sales Market Share by Regions (2015-2020)
Table 41. Global Anti-Ageing Drugs Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Anti-Ageing Drugs Sales by Countries (2015-2020) (K Units)
Table 43. North America Anti-Ageing Drugs Sales Market Share by Countries (2015-2020)
Table 44. North America Anti-Ageing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Anti-Ageing Drugs Revenue Market Share by Countries (2015-2020)
Table 46. Europe Anti-Ageing Drugs Sales by Countries (2015-2020) (K Units)
Table 47. Europe Anti-Ageing Drugs Sales Market Share by Countries (2015-2020)
Table 48. Europe Anti-Ageing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Anti-Ageing Drugs Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Anti-Ageing Drugs Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Anti-Ageing Drugs Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Anti-Ageing Drugs Sales by Countries (2015-2020) (K Units)
Table 53. South America Anti-Ageing Drugs Sales Market Share by Countries (2015-2020)
Table 54. South America Anti-Ageing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Anti-Ageing Drugs Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Anti-Ageing Drugs Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Anti-Ageing Drugs Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Anti-Ageing Drugs Revenue Market Share by Countries (2015-2020)
Table 60. Global Anti-Ageing Drugs Sales by Type (2015-2020) (K Units)
Table 61. Global Anti-Ageing Drugs Sales Share by Type (2015-2020)
Table 62. Global Anti-Ageing Drugs Revenue by Type (2015-2020) (USD Million)
Table 63. Global Anti-Ageing Drugs Revenue Share by Type (2015-2020)
Table 64. Global Anti-Ageing Drugs Sales by Application (2015-2020) (K Units)
Table 65. Global Anti-Ageing Drugs Sales Share by Application (2015-2020)
Table 66. Global Anti-Ageing Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Anti-Ageing Drugs Market Share Forecast by Regions (2021-2025)
Table 68. Global Anti-Ageing Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Anti-Ageing Drugs Market Share Forecast by Type (2021-2025)
Table 70. Global Anti-Ageing Drugs Sales Forecast by Application (2021-2025)
Table 71. Global Anti-Ageing Drugs Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-Ageing Drugs Picture
Figure 2. Global Sales Market Share of Anti-Ageing Drugs by Type in 2019
Figure 3. Hormonal Therapy Picture
Figure 4. Antioxidants Picture
Figure 5. Enzymes Picture
Figure 6. Stem Cells Picture
Figure 7. Others Picture
Figure 8. Anti-Ageing Drugs Sales Market Share by Application in 2018
Figure 9. Skin Picture
Figure 10. Hair Picture
Figure 11. Others Picture
Figure 12. Global Anti-Ageing Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Anti-Ageing Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Anti-Ageing Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Anti-Ageing Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Anti-Ageing Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Anti-Ageing Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Anti-Ageing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Anti-Ageing Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Anti-Ageing Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Anti-Ageing Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Anti-Ageing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Anti-Ageing Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Anti-Ageing Drugs Sales Market Share by Countries in 2018
Figure 49. North America Anti-Ageing Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Anti-Ageing Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Anti-Ageing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Anti-Ageing Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Anti-Ageing Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Anti-Ageing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Anti-Ageing Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Anti-Ageing Drugs Revenue Market Share by Regions 2019
Figure 65. China Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Anti-Ageing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Anti-Ageing Drugs Sales Market Share by Countries in 2019
Figure 72. South America Anti-Ageing Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Anti-Ageing Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Anti-Ageing Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Anti-Ageing Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Anti-Ageing Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Anti-Ageing Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Anti-Ageing Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Anti-Ageing Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Anti-Ageing Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Anti-Ageing Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Anti-Ageing Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Anti-Ageing Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Anti-Ageing Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
抗血管内皮増殖因子（抗VEGF）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke…- 抗インフルエンザ薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-influenza Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 抗喘息薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti Asthma Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 24300 million by 2025, from USD 21410 million in 2019. The Anti Asthma Drugs ma…
- 抗ウイルス薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Viral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Viral Drugs market repo…
- 抗てんかん薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti Epilepsy Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 3927.2 million by 2025, from USD 3620.1 million in 2019. The Anti Epilepsy Dr…